Literature DB >> 25136176

Correlation of Cytology and Colposcopic Findings Using Reid's Index in VIA-Positive Women.

Nisarg Dharaiya1, Nandita Maitra1.   

Abstract

INTRODUCTION: Cervical cancer is the most common cancer among Indian women. Only 5 % of women in developing countries have ever been screened for cervical abnormalities.
OBJECTIVES: To study the correlation of cytology and colposcopy in VIA-positive women attending the Gynaecology clinic.
MATERIALS AND METHODS: This prospective cross-sectional study on 200 symptomatic women compares the role of cytology and colposcopy in the assessment of subjects testing positive for acetowhite lesions on the cervix after application of 5 % acetic acid (VIA).
RESULTS: 200/637 women screened in OPD tested VIA positive, giving a positivity rate of 31 %. Six smears were reported as LGSIL or HGSIL giving a cytological abnormality rate of 3 %. The association between cytology and Reid's score was statistically significant at a p value of 0.02. Of the 4 cases with biopsy-confirmed invasive cancer, cytology reported 2 as LGSIL and 2 as HGSIL. Colposcopy reported all these women as CIN 2/3.
CONCLUSION: The accuracies of Pap smear cytology and colposcopy in the diagnosis of precancerous and cancerous lesions of cervix were good.

Entities:  

Keywords:  Cervical cancer; Colposcopy; Reid’s Index; VIA positivity

Year:  2014        PMID: 25136176      PMCID: PMC4126948          DOI: 10.1007/s13224-014-0513-8

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  13 in total

1.  The distribution of neoplasia arising on the cervix: results from the ALTS trial.

Authors:  Richard S Guido; Jose Jeronimo; Mark Schiffman; Diane Solomon
Journal:  Am J Obstet Gynecol       Date:  2005-10       Impact factor: 8.661

2.  Women in a region with high incidence of cervical cancer warrant immediate colposcopy for low-grade squamous intraepithelial lesion on cervical cytology.

Authors:  C Phongnarisorn; J Srisomboon; S Siriaungkul; S Khunamornpong; P Suprasert; K Charoenkwan; C Cheewakriangkrai; S Siriaree; K Saphan
Journal:  Int J Gynecol Cancer       Date:  2006 Jul-Aug       Impact factor: 3.437

3.  Cancer projection by the turn of century-Indian science.

Authors:  N S Murthy; A Juneja; A Sehgal; A K Prabhakar; U K Luthra
Journal:  Indian J Cancer       Date:  1990-06       Impact factor: 1.224

4.  Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities.

Authors:  M I Shafi; D M Luesley; J A Jordan; J A Dunn; T P Rollason; M Yates
Journal:  Br J Obstet Gynaecol       Date:  1997-05

5.  Evaluation of cytologic screening results of the cervix.

Authors:  S Yalti; B Gürbüz; R Bilgiç; Y Cakar; S Eren
Journal:  Int J Gynecol Cancer       Date:  2005 Mar-Apr       Impact factor: 3.437

Review 6.  ASCUS in Papanicolaou smears. Problems, controversies, and potential future directions.

Authors:  Cindy M McGrath
Journal:  Am J Clin Pathol       Date:  2002-06       Impact factor: 2.493

7.  Visual inspection with acetic acid and cytology in the early detection of cervical neoplasia in Kolkata, India.

Authors:  P S Basu; R Sankaranarayanan; R Mandal; C Roy; P Das; D Choudhury; D Bhattacharya; R Chatterjee; K Dutta; S Barik; V Tsu; R N Chakrabarti; M Siddiqi
Journal:  Int J Gynecol Cancer       Date:  2003 Sep-Oct       Impact factor: 3.437

8.  An analysis of 84244 patients from the British Columbia cytology-colposcopy program.

Authors:  J L Benedet; J P Matisic; M A Bertrand
Journal:  Gynecol Oncol       Date:  2004-01       Impact factor: 5.482

9.  Management of women with mild and moderate cervical dyskaryosis.

Authors:  G Flannelly; D Anderson; H C Kitchener; E M Mann; M Campbell; P Fisher; F Walker; A A Templeton
Journal:  BMJ       Date:  1994-05-28

10.  [Cervical cytologic reports of ASCUS and LSIL. Cyto-histological correlation and implication for management].

Authors:  M G Fallani; C Penna; M Fambrini; M Marchionni
Journal:  Minerva Ginecol       Date:  2002-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.